Jean-paul Prieels

Biography

Dr. Jean-Paul Prieels, Ph.D., serves as Co-Owner and Managing Partner of LSP. Dr. Prieels served as Senior Vice President of Research & Development at GlaxoSmithKline Biologicals (GSK Biologicals) until January 2011. He joined GlaxoSmithKline Biologicals in 1987 as an Associate Director of R&D Projects Evaluation. His responsibilities gradually expanded to lead the global vaccine R&D development activities in Rixensart, Belgium. His career spans from basic research to process and product development. He was instrumental in developing several commercially available vaccines, such as rotavirus, human papilloma virus (HPV), pneumococcal conjugates and others. He served as the Head of Research at GSK Vaccines. He serves the Chairman of Immune Health. He has been a Non-Executive Director of Bone Therapeutics SA since March 01, 2015. He has been a Director of Okairos AG since September 14, 2011. He serves as a Director of PROMETHERA Biosciences S.A./N.V., Vaximm AG and DNAlytics. He serves as a Director and Member of Scientific Advisory Board at ABIVAX S.A. He served as a Director of TheraDiag SA from July 3, 2012 to July 11, 2016. Since 2007, he has been a Member of the Scientific Advisory Board of the Singapore Bioprocessing Technology Institute. He has been a Member of Supervisory Board at LEUKOCARE AG since July 2015. He serves as a Member of Scientific Advisory Board at MolMed S.p.A. He has been a Member of Scientific Advisory Board at CureVac AG since March 30, 2016. He serves as a Member of Strategic Advisory Board at Univercells SA. He serves as a Director at PDC line Pharma SAS. He has been a Non-Executive Director at Nouscom AG since 2016. He served as a Director of Pevion Biotech AG since April 21, 2011 and Henogen from 2000 to 2008. Dr. Prieels graduated from the Free University of Brussels, Belgium and holds a PhD in Biochemistry from Universite Libre de Bruxelles in Belgium in 1975.  

Research Interest

  Biochemistry